Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response kinetics after Boostrix pertussis booster vaccination
NL-OMON52999Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2017
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of acellular pertussis vaccine in pertussis, sponsored by Leiden University Medical Center. Primary endpoints: Innate and adaptive immune cell kinetics, Identification of antigen-specific memory B cells and plasma cells and 1 more. Started Jun 2017; status: active, not recruiting.
02
Drugs
acellular pertussis vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on NL-OMON52999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52999.